Article
Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors.
Future oncology (London, England) - 1 Feb 2008
Knowles Margaret A
Abstract excerpt
Bladder cancer presents several challenges in clinical management. For the large group of noninvasive tumors, key problems are the development of multiple recurrences that require long-term surveillance and a lack of effective therapies to prevent recurrence. For the smaller group of poor prognosis patients with invasive disease, novel therapies are urgently needed. The identification of mutations of FGF receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.